This will be the 14th International Conference on Thalassaemia and Other Haemoglobinopathies & the 16th TIF Conference for Patients and Parents. This year the conference will be held from November 17 till 19, at the Grand Hotel Palace in Thessaloniki, Greece.
On Saturday, November 17, 2017, Cerus will be presenting a Satellite Symposium from 17:30 – 19:00 titled, INTERCEPTTM Pathogen Inactivation for Red Blood Cells: Upcoming clinical evidence in chronic transfusion therapy.
Here are details on the speakers and their focus areas:
- Red Blood Cell Pathogen Inactivation: Improving the Safety of Transfusion Therapy
Dr. Richard J Benjamin – Cerus Corporation, Concord, USA
- Pathogen inactivated Red Blood Cells in Support of Sickle Cell Disease
Prof. John Porter – University College Hospital, London, UK
- Clinical Experience with Pathogen Inactivated Red Blood Cells in Treatment of Thalassemia
Prof. Yesim Aydinok – Ege University, Pediatric Hematology, Izmir, Turkey
For more information on the conference and the programme, visit the TIF website.